Literature DB >> 17942802

The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma.

Iris M C van der Ploeg1, Renato A Valdés Olmos, Omgo E Nieweg, Emiel J Th Rutgers, Bin B R Kroon, Cornelis A Hoefnagel.   

Abstract

UNLABELLED: The recently introduced SPECT/CT integrates the physiologic data of SPECT with the anatomic data of CT into a single image. The purpose of this pilot study was to explore the additional value of SPECT/CT in breast cancer patients and melanoma patients with inconclusive planar image findings.
METHODS: Thirty-one patients had planar lymphoscintigrams showing unexpected lymphatic drainage, 6 had lymphoscintigrams that were difficult to interpret, and 3 showed no drainage on planar imaging. SPECT/CT was performed immediately after delayed planar imaging.
RESULTS: In 4 patients, SPECT/CT showed 6 additional sentinel nodes, of which 2 were tumor-positive and led to upstaging and tailored management in 5% of patients. SPECT/CT depicted sentinel nodes in 3 patients whose delayed planar imaging had shown no drainage.
CONCLUSION: SPECT/CT was of additional value in finding the exact anatomic location of sentinel nodes in patients with inconclusive planar image findings. SPECT/CT also detected sentinel nodes in addition to those found on planar images, and SPECT/CT detected sentinel nodes in patients whose planar images had shown none.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942802     DOI: 10.2967/jnumed.107.043372

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

Review 1.  SPECT/CT and tumour imaging.

Authors:  Gad Abikhzer; Zohar Keidar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-29       Impact factor: 9.236

2.  Multifaceted role of lymphatic mapping by SPECT/CT hybrid imaging in the multimodality management of patients with cancer.

Authors:  Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-22       Impact factor: 9.236

3.  The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer.

Authors:  Iris M C van der Ploeg; Omgo E Nieweg; Bin B R Kroon; Emiel J T Rutgers; Marie-Jeanne T F D Baas-Vrancken Peeters; Wouter V Vogel; Cornelis A Hoefnagel; Renato A Valdés Olmos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-13       Impact factor: 9.236

4.  Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?

Authors:  Jean-Cyril Bourre; Raoul Payan; Delphine Collomb; Céline Gallazzini-Crepin; Alex Calizzano; Marie-Dominique Desruet; Dominique Pasquier; Michel Bolla; Daniel Fagret; Jean-Philippe Vuillez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236

5.  SPECT-CT and real-time intraoperative imaging: new tools for sentinel node localization and radioguided surgery?

Authors:  Renato A Valdés Olmos; Sergi Vidal-Sicart; Omgo E Nieweg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01       Impact factor: 9.236

6.  Combined SPECT and Multidetector CT for Prostate Cancer Evaluations.

Authors:  Carina Mari Aparici; David Carlson; Nhan Nguyen; Randall A Hawkins; Youngho Seo
Journal:  Am J Nucl Med Mol Imaging       Date:  2012

7.  First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT.

Authors:  Thomas Wendler; Ken Herrmann; Andreas Schnelzer; Tobias Lasser; Joerg Traub; Olivier Kutter; Alexandra Ehlerding; Klemens Scheidhauer; Tibor Schuster; Marion Kiechle; Markus Schwaiger; Nassir Navab; Sibylle I Ziegler; Andreas K Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-31       Impact factor: 9.236

8.  The hidden sentinel node and SPECT/CT in breast cancer patients.

Authors:  Iris M C van der Ploeg; Renato A Valdés Olmos; Bin B R Kroon; Emiel J T Rutgers; Omgo E Nieweg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-20       Impact factor: 9.236

9.  Value and efficiency of sentinel lymph node diagnostics in patients with penile carcinoma with palpable inguinal lymph nodes as a new multimodal, minimally invasive approach.

Authors:  Ulf Lützen; Maaz Zuhayra; Marlies Marx; Yi Zhao; Christian Colberg; Stephanie Knüpfer; René Baumann; Katharina Charlotte Kähler; Klaus-Peter Jünemann; Carsten Maik Naumann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-12       Impact factor: 9.236

10.  False-negative sentinel node biopsy.

Authors:  Omgo E Nieweg
Journal:  Ann Surg Oncol       Date:  2009-06-12       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.